• +1 700 888 1234

  • Effingerstrasse 40 3008 Bern Switzerland

Association of Patients with Respiratory Failure and Lung Transplantation joins LuCE

We are pleased to welcome another new member to Lung Cancer Europe as the Bulgarian Association of Patients with Respiratory […]

ALK Positive Europe joins LuCE

We are pleased to welcome another new member to Lung Cancer Europe as Alk Positive Europe joins the LuCE family. […]

FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer

Some positive news last week when the U.S. Food and Drug Administration (FDA) approved alectinib as an adjuvant treatment for […]

BMS Press Release is out now

Bristol Myers Squibb has released a new Press Release announcing that the European Medicines Agency (EMA) has validated the marketing authorization application for repotrectinib. Repotrectinib […]

LuCE attending the European Medicines Agency (EMA) in Amsterdam

November 14th – 15th in Amsterdam We are delighted to announce that Lung Cancer Europe (LuCE) is participating in a two-day meeting […]

Introducing our newest Member: Lungunion Austria

About the Organization Lungunion Austria  The Lungunion Austria is a patient organization (NGO and self-aid organization) for people with airway […]


Privacy policy
Terms & Conditions

© 2025 Lung Cancer Europe – All Rights Reserved